Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Amneal Pharmaceuticals Inc (NY: AMRX )

3.910 USD +0.060 (+1.56%)
Streaming Delayed Price Updated: 2:43 PM EDT, Sep 30, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 276,046
Open 3.830
Bid (Size) 3.900 (10)
Ask (Size) 3.910 (7)
Prev. Close 3.850
Today's Range 3.820 - 3.960
52wk Range 2.400 - 5.790
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Wishbone Medical Appoints Jeff George to Board of Directors
From GlobeNewswire News Releases
Amneal to Virtually Participate at the Morgan Stanley Global Healthcare Conference
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (the “Company”) today announced that members of management will participate at the Morgan Stanley Global Healthcare Conference held on September 15, 2020. The... 
From Business Wire News Releases

Performance

YTD
-18.03%
-18.03%
1 Month
-4.87%
-4.87%
3 Month
-17.86%
-17.86%
6 Month
+12.36%
+12.36%
1 Year
+34.83%
+34.83%

More News

Read More
Amneal Receives Abbreviated New Drug Application Approval for Lidocaine Patch, 5%
From Business Wire News Releases
Cosette Pharmaceuticals Appoints Seasoned Industry Executive Apurva Saraf as President and Chief Executive Officer
From GlobeNewswire News Releases
Phathom Pharmaceuticals Announces Appointment of Todd Branning as Chief Financial Officer
From GlobeNewswire News Releases
Amneal Reports Second Quarter 2020 Financial Results
From Business Wire News Releases
Amneal Pharmaceuticals Breaks Below 200-Day Moving Average - Notable for AMRX
Tags Stocks
From Market News Video
NetworkNewsBreaks – Eastman Kodak Co. (NASDAQ: KODK) Stock Heads Skyward after Company Receives First-of-Its-Kind Government Loan
From InvestorBrandNetwork
Amneal Launches Generic Fluphenazine Following ANDA Approval by FDA
From Business Wire News Releases
Amneal to Report Second Quarter 2020 Results on August 6, 2020
From Business Wire News Releases
Trump’s ‘Buy American’ order on essential drugs looks ‘toothless,’ analysts say
Tags General Medical Products PJP
From MarketWatch
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.